Sign in

Doug Weiss

Research Analyst at DWS Investment GMBH

Douglas S. Weiss, CFA, is the Founder and Managing Principal at DSW Investment, LLC, specializing in value investing across equities and fixed income for individuals and pension clients. He has covered and conducted research on companies such as S&W Seed Company, The Glimpse Group, Shuttle Pharma, SenesTech, Peraso Inc., Reliq Health Technologies, Dyadic International, Arianne Phosphate, and Syra Health Corp, with a disciplined focus on small cap stocks, corporate bonds, REITs, and closed-end funds. Weiss began his career over 19 years ago as an equity research analyst at Salomon Brothers and CIBC World Markets, later working in private wealth management at Foster & Foster, LLC, before founding DSW Investment in 2011. A Chartered Financial Analyst (CFA) and Registered Investment Advisor, he maintains FINRA registration and brings extensive expertise in security analysis, portfolio construction, and asset valuation.

Doug Weiss's questions to MIL leadership

Question · Q3 2015

Doug Weiss of DSW Investment inquired about the performance of the supply chain business, the strategic goal of the banking initiative, associated credit risks, and the plan for the discontinued Wabush asset.

Answer

CEO Gerardo Cortina acknowledged that the supply chain business was affected by the struggling steel industry, leading to a focus on cost and working capital reduction. He and CFO Sam Morrow explained the banking initiative aims to offer financial services to their existing customer base to improve margins, not just to invest cash. Morrow added that credit risk in factoring would be mitigated with additional protection and that the Wabush asset rationalization is pending the conclusion of CCAA proceedings.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts